Unapproved Dangerous Medications in the U.S.
The FDA's approval of Ozempic as a weight-loss drug in 2021 marked a significant milestone in obesity treatment.
Following this, the FDA approved other GLP-1 agonists for weight loss, offering hope to millions battling obesity—a leading cause of severe health conditions.
However, the popularity of these medications led to a supply shortage, creating a gap filled by counterfeit drugs.
- Counterfeit GLP-1 drugs are often marketed as affordable alternatives.
- They exploit regulatory loopholes to enter the U.S.
- Ingredients from unregulated labs are frequently labeled “for research purposes” or “not for human consumption,” evading U.S. regulations.
These medications have transformed lives, but their popularity outstripped supply, creating a dangerous gap filled by counterfeit drugs.
The legitimate pharmaceutical industry faces a critical challenge: warning consumers about hazardous knockoffs.
Author's summary: Counterfeit medications threaten the U.S.
More News
- The 5 Biggest State Tax Cuts for Millionaires this Year
- The Apple Watch Series 11 is a solid smartwatch with minor upgrades
- What the Sixers are expecting in Joel Embiid’s preseason debut | NorthPennNow
- Best Multipurpose and Super Glues From Our Tests - Consumer Reports
- All of the Medications Announced as Part of FDA’s National Priority Voucher Program | PharmExec